ZYTHERA

Pioneering Enzyme Replacement Therapies for Lysosomal Storage Diseases.

[ZYTHERA @ZytheraBiotech]

Announcing our #Seed #Funding #Round as we take the next step in our mission to transform the future of #enzyme #replacement #therapies for #lysosomal #storage #diseases. With a passionate team, early proof-of-concept data, and a clear path to the clinic, we’re ready to scale!

[ZYTHERA @ZytheraBiotech]

We’re excited our team is part of this @BBSRC Mission Hub at the forefront of next generation therapeutics development!

[Giovanni Stracquadanio @DrStracquadanio]

Excited to be part of the “Engineered Genetic Control Systems for Advanced Therapeutics” hub led by @RosserLab. We’ll be developing new therapies for #lysosomal #storage #diseases affecting the #CNS and bones using #AI and #engbio. @SBSatEd @EdEngBio

https://t.co/8rWPGZF5YJ

[SynBioBeta @SynBioBeta]

A new collaboration aims to improve the creation of safer and more effective therapeutics, including enzyme replacement therapy, for a diverse range of genetic diseases. https://t.co/wkqMlM8ul4

[IBioIC @IBioIC]

Researchers at the @EdinburghUni, in partnership with the synthetic DNA company @neochromosome and supported by IBioIC, have unveiled a tool utilising AI to assist with the process of enzyme selection for therapeutic treatments.
https://t.co/GLefMszijX

[Giovanni Stracquadanio @DrStracquadanio]

It was great to meet #patients and #doctors of @EdinburghKidney. Here collaborator, Dr Eve Miller-Hodges, introducing our #Fabry #ERT deimmunization project and the power #AI in drug discovery. Exciting times ahead! @SBSatEd @EdEngBio @UKRI_News @rarediseaseuk

[ZYTHERA @ZytheraBiotech]

We had a great meeting yesterday with @SciTechgovuk #EngBio team and @IBioIC presenting our #AI and #EngBio platform to make new #ERTs for lysosomal storage diseases #LSD. Excellent feedback and great new connections. @SBSatEd @EdEngBio

[Giovanni Stracquadanio @DrStracquadanio]

Very excited to lead one of the #AI for #health #research projects with @RosserLab and Dr Eve Miller-Hodges. We will develop new methods to design and make less #immunogenic #ERTs for #Fabry disease. https://t.co/WCL8Dsg87O @SBSatEd @EdEngBio @MPSSocietyUK @UKRI_News

[Anima Sutradhar @astrdhr]

Hi everyone, please come along to what will be a very interesting talk by @sudpinglay! This will be a joint session with @EUSynBioS and @EdEngBio/@SBSatEd, taking place in the Waddington Seminar room. All welcome to join in-person or via the Zoom link 🧬

[ZYTHERA @ZytheraBiotech]

Looking forward to help patients with #Lysosomal #Storage #Diseases #LSD doing what we do best: #AI and #engbio. Thanks @scotent for the support.

[Biological Sciences | University of Edinburgh @SBSatEd]

Funding boost for scientists using AI to identify treatments for rare diseases

ZYTHERA (enZYme THERApeutics), led by @RosserLab @DrStracquadanio is engineering enzyme replacement therapies (ERTs) for lysosomal storage diseases (LSDs) using AI

➡️ https://t.co/0FyqBQCdug

[ZYTHERA @ZytheraBiotech]

@ScotEntNews @EdinburghUni @scotent @EdinInnovations Thank you for the support @scotent. @DrStracquadanio @RosserLab

[Scottish Enterprise News @ScotEntNews]

Research @EdinburghUni using AI to develop faster and cheaper enzyme replacement therapies for rare diseases that can impact children is awarded £74,600 @scotent spin-out funding to aid commercialisation #ZYTHERA #LifeSciences #AI @EdinInnovations https://t.co/JjarjNNipC